Several investigations point to the role of XRCC2 mutations and polymorphisms in various cancers such as breast cancer, colorectal cancer, brain cancer, oral and Lynch syndrome and esophageal adenocarcinoma (50). Here, XRCC2 is linked to esophageal adenocarcinoma.